Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan

BSE758.008.7 (+1.16 %)

PREV CLOSE ( ) 749.30

OPEN PRICE ( ) 750.80

BID PRICE (QTY) 755.60 (1)

OFFER PRICE (QTY) 757.75 (34)

VOLUME 577

TODAY'S LOW / HIGH ( )750.80 763.15

52 WK LOW / HIGH ( )556.05 802.6

NSE755.505.7 (+0.76 %)

PREV CLOSE( ) 749.80

OPEN PRICE ( ) 750.00

BID PRICE (QTY) 755.50 (6)

OFFER PRICE (QTY) 756.35 (1)

VOLUME 16532

TODAY'S LOW / HIGH( ) 748.75 763.10

52 WK LOW / HIGH ( )563.9 804

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 09-09 1936

Management Info

S Sambhu Prasad - Chairman S Sambhu Prasad - Managing Director

Registered Office

Address New 103 (Old 42-45),Luz Church Road,Mylapore,
Chennai,
Tamil Nadu-600004

Phone 044- 24994465 / 24669000 / 18004254545

Email customercare@amrutanjan.com

Website www.amrutanjan.com

Registrars Details

Cameo Corporate Services Ltd

Subramanian Buildings No 1 ,Club House Road,,Chennai

Listing : BSE, NSE, Chennai

NEWS

08May Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that the exchange has received the d..

07May Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that it enclosed disclosure under Re..

04Mar Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that it enclosed disclosure under Re..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	174.51	398.34
Gross Profit	237.08	536.45
Operating Profit	253.38	589.34
Net Sales	1169.94	3796.36

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE) 8872.00 (3.52%)	M.Cap ( in Cr)20503.01
Astrazeneca Pharma I (BSE) 5774.00 (2.39%)	M.Cap ( in Cr)14435.00
Pfizer (BSE) 4391.50 (1.28%)	M.Cap ( in Cr)20090.12
RPG Life Sciences (BSE) 1525.60 (1.74%)	M.Cap ( in Cr)2518.48
Zydus Lifesciences (BSE) 1032.65 (2.37%)	M.Cap ( in Cr)103969.13

Shareholding Pattern

	PROMOTERS	50.59%
	NON-INSTITUTION	40.74%
	MUTUAL FUNDS/UTI	6.79%
	FI/BANKS/INSURANCE	0.09%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Sundaram Small Cap ...	1.02
DSP Small Cap Fund-Reg(G)	0.70

Risk Disclosures on Derivatives

Smart Quotes

AMRUTANJAN HEALTH CARE LTD.